Exelixis, Inc. (EXEL) Chops 70 Percent Of Workforce After Prostate Drug Cabozantinib Fails Pivotal Study
Novo Nordisk A/S (NVO) Drops Inflammatory Disorder Business; 400 Staffers Impacted
Novartis AG (NVS)'s New Heart Drug Cuts Cardiovascular Death Risk By 20 Percent; "Most Exciting Ever" Med Points To Huge Sales
Early Phase 3 Data Suggest Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN) Drug May Halve Heart Risk
Belgium Biotech ThromboGenics NV (TBGNF) Cuts Around A Fifth Of Employees
Resverlogix Corporation (RVX.TO)'s RVX-208 Leads To A 77 Percent Relative Risk Reduction Of Major Heart Events
San Diego's ACADIA Pharmaceuticals, Inc. (ACAD) Wins FDA Breakthrough Therapy Designation For NUPLAZID™
Bristol-Myers Squibb Company (BMY) Gives Back Rights To Alder Biopharmaceuticals Inc.'s Promising Arthritis Drug Clazakizumab
Bayer HealthCare (BAY) Starts Its Own Accelerator
Shareholders Revolt Over GlaxoSmithKline (GSK)'s Plans To Shake Up Board; Investors Call For Speedy Departure Of Chairman Gent
Baxter International, Inc. (BAX)'s Hunt For Space In Cambridge Triggers A Counter Effort In Illinois
Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline (GSK)'s Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden
Amgen (AMGN) Submits Marketing Authorization Application For Cholesterol-Lowering Medication Evolocumab
Amgen (AMGN) Submits Marketing Authorization Application For Talimogene Laherparepvec
Clearside Biomedical Snags $16 Million Series B Financing
GC-Rise Locks In $15 Million
Cytori Therapeutics, Inc. (CYTX) Consolidates European Operations To Newly Opened Welsh Manufacturing Facility
XBiotech USA, Inc. Halts Cancer Study On Positive Phase 3 Results
See All News >
Gilead Sciences, Inc. (GILD), "The New Genentech (RHHBY)," Remaps Massive Foster City Campus
Johnson & Johnson (JNJ) Seeks Buyer For Struggling Medical Device Unit Cordis Corporation (JNJ); Deal Could Fetch Up To $2 Billion
AstraZeneca PLC (AZN) Pops On Possibility Of Another Pfizer Inc. (PFE) Bid; Start Of New Cancer Trial
Hundreds Of Girls Struck With Mystery Illness; Possibly Linked To Merck & Co., Inc. (MRK)'s Gardasil
Novartis AG (NVS) Follows Biogen Idec, Inc. (Massachusetts) (BIIB), GlaxoSmithKline (GSK)'s Footsteps With New State Of The Art Offices; Space Reflects "The Novartis Way Of Working"
Short Men Make Better Boyfriends And Husbands, New York University Study
Baxter International, Inc. (BAX) May Move Headquarters From Illinois To Boston
Piramal Life Sciences Exits Drug Discovery Business; 200 Scientists Affected
Bayer AG (BAYZF), Boehringer Ingelheim Corporation, Perrigo Company (PRGO), And Sanofi (France) (SAN.PA) Linked To Omega Pharma NV (0OMEP.BR) Sale; Deal Could Cost More Than $5.3 Billion
Eli Lilly and Company (LLY), Takeda Pharmaceutical Co. Ltd. (TKPYY) Lose Bid To Overturn $9 Billion Award For Hiding Actos' Cancer Risk
Amgen (AMGN)'s Cholesterol Lowering Drug Succeeds In Phase 3 Trial
Leukemia Drug Troubles Force Ariad Pharmaceuticals, Inc. (ARIA) To Shrink Size Of Footprint In Kendall Square
Achillion Pharmaceuticals, Inc. (ACHN) Hits One Year High After Rumors Gilead Sciences, Inc. (GILD) Might Buy It Out
GlaxoSmithKline (GSK)'s Ebola Vaccine To Be Tested For Safety In Humans As Early As Next Week
Merck Serono Breaks Ground On $105 Million Plant; Will Be The Company's Second Largest Manufacturing Facility Worldwide
Menlo Park Startup Armetheon Snags $7 Million Series A Financing
BioPharm Executive: Attack Of The Job-Stealing Robots
Fresh From Co-Founding Massively Financed Juno Therapeutics, Arch Venture Partners Banks $400 Million+ To Back New Biotechs
See All News >
//-->